All Resources

CDC and FDA Recommending a Pause in the Use of the J&J COVID-19 Vaccine

CDC and FDA Recommending a Pause in the Use of the J&J COVID-19 Vaccine

The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) are reviewing data involving six U.S. cases of a rare type of blood clot in individuals after receiving the J&J COVID-19 vaccine that were reported to the Vaccine Adverse Event Reporting System (VAERS).

Read the FAQs about this action.

We’re currently updating our systems. Some features may temporarily be impacted. Learn More